Evaluation of [(18)F]-(-)-norchlorofluorohomoepibatidine ([(18)F]-(-)-NCFHEB) As a PET Radioligand to Image the Nicotinic Acetylcholine Receptors in Non-human Primates

Overview

Journal Nucl Med Biol

Publisher Elsevier

Specialties Biology
Nuclear Medicine

Date 2015 Apr 11

PMID 25858513

Citations 13

Authors

Frederic Bois

Jean-Dominique Gallezot

Ming-Qiang Zheng

Shu-Fei Lin

Irina Esterlis

Kelly P Cosgrove

Richard E Carson

Yiyun Huang

Affiliations

Soon will be listed here.

Abstract

Introduction: The aims of the present study were to develop an optimized microfluidic method for the production of the selective nicotinic acetylcholine α4β2 receptor radiotracer [(18)F]-(-)-NCFHEB ([(18)F]-Flubatine) and to investigate its receptor binding profile and pharmacokinetic properties in rhesus monkeys in vivo.

Methods: [(18)F]-(-)-NCFHEB was prepared in two steps, a nucleophilic fluorination followed by N-Boc deprotection. PET measurements were performed in rhesus monkeys including baseline and preblocking experiments with nicotine (0.24 mg/kg). Radiometabolites in plasma were measured using HPLC.

Results: [(18)F]-(-)-NCFHEB was prepared in a total synthesis time of 140 min. The radiochemical purity in its final formulation was >98% and the mean specific radioactivity was 97.3 ± 16.1 GBq/μmol (n = 6) at end of synthesis (EOS). In the monkey brain, radioactivity concentration was high in the thalamus, moderate in the putamen, hippocampus, frontal cortex, and lower in the cerebellum. Nicotine blocked 98-100% of [(18)F]-(-)-NCFHEB specific binding, and the non-displaceable distribution volume (VND) was estimated at 5.9 ± 1.0 mL/cm(3) (n = 2), or 6.6 ± 1.1 mL/cm(3) after normalization by the plasma free fraction fP. Imaging data are amenable to kinetic modeling analysis using the multilinear analysis (MA1) method, and model-derived binding parameters display good test-retest reproducibility. In rhesus monkeys, [(18)F]-(-)-NCFHEB can yield robust regional binding potential (BPND) values (thalamus = 4.1 ± 1.5, frontal cortex = 1.2 ± 0.2, putamen = 0.96 ± 0.45, and cerebellum = 0.10 ± 0.29).

Conclusion: An efficient microfluidic synthetic method was developed for preparation of [(18)F]-(-)-NCFHEB. PET examination in rhesus monkeys showed that [(18)F]-(-)-NCFHEB entered the brain readily and its regional radioactivity uptake pattern was in accordance with the known distribution of α4β2 receptors. Estimated non-displaceable binding potential (BPND) values in brain regions were better than those of [(18)F]2-FA and comparable to [(18)F]AZAN. These results confirm previous findings and support further examination of [(18)F]-(-)-NCFHEB in humans.

Citing Articles

Imaging Cholinergic Receptors in the Brain by Positron Emission Tomography.

Zhang J, Fu H, Lin R, Zhou J, Haider A, Fang W J Med Chem. 2023; 66(16):10889-10916.

PMID: 37583063 PMC: 10461233. DOI: 10.1021/acs.jmedchem.3c00573.

Cholinergic system adaptations are associated with cognitive function in people recently abstinent from smoking: a (-)-[F]flubatine PET study.

Calakos K, Hillmer A, Anderson J, LeVasseur B, Baldassarri S, Angarita G Neuropsychopharmacology. 2023; 48(4):683-689.

PMID: 36681758 PMC: 9938267. DOI: 10.1038/s41386-023-01535-1.

Intrahippocampal blockade of nicotinic or muscarinic receptors fails to impair nonnavigational spatial memory in macaques.

LaFlamme E, Malkova L, Forcelli P Behav Neurosci. 2021; 135(4):581-590.

PMID: 33630614 PMC: 8384945. DOI: 10.1037/bne0000444.

PET Imaging Estimates of Regional Acetylcholine Concentration Variation in Living Human Brain.

Smart K, Naganawa M, Baldassarri S, Nabulsi N, Ropchan J, Najafzadeh S Cereb Cortex. 2021; 31(6):2787-2798.

PMID: 33442731 PMC: 8355478. DOI: 10.1093/cercor/bhaa387.

Dealing with PET radiometabolites.

Ghosh K, Padmanabhan P, Yang C, Mishra S, Halldin C, Gulyas B EJNMMI Res. 2020; 10(1):109.

PMID: 32997213 PMC: 7770856. DOI: 10.1186/s13550-020-00692-4.

References

Pajevic S, Daube-Witherspoon M, Bacharach S, Carson R . Noise characteristics of 3-D and 2-D PET images. IEEE Trans Med Imaging. 1998; 17(1):9-23. DOI: 10.1109/42.668691. View

Coyle J, Price D, DeLong M . Alzheimer's disease: a disorder of cortical cholinergic innervation. Science. 1983; 219(4589):1184-90. DOI: 10.1126/science.6338589. View

Deuther-Conrad W, Patt J, Feuerbach D, Wegner F, Brust P, Steinbach J . Norchloro-fluoro-homoepibatidine: specificity to neuronal nicotinic acetylcholine receptor subtypes in vitro. Farmaco. 2004; 59(10):785-92. DOI: 10.1016/j.farmac.2004.07.004. View

Horti A, Gao Y, Kuwabara H, Dannals R . Development of radioligands with optimized imaging properties for quantification of nicotinic acetylcholine receptors by positron emission tomography. Life Sci. 2009; 86(15-16):575-84. PMC: 2848883. DOI: 10.1016/j.lfs.2009.02.029. View

Rueckert D, Sonoda L, Hayes C, Hill D, Leach M, Hawkes D . Nonrigid registration using free-form deformations: application to breast MR images. IEEE Trans Med Imaging. 1999; 18(8):712-21. DOI: 10.1109/42.796284. View

Breese C, Lee M, Adams C, Sullivan B, Logel J, Gillen K . Abnormal regulation of high affinity nicotinic receptors in subjects with schizophrenia. Neuropsychopharmacology. 2000; 23(4):351-64. DOI: 10.1016/S0893-133X(00)00121-4. View

Innis R, Cunningham V, Delforge J, Fujita M, Gjedde A, Gunn R . Consensus nomenclature for in vivo imaging of reversibly binding radioligands. J Cereb Blood Flow Metab. 2007; 27(9):1533-9. DOI: 10.1038/sj.jcbfm.9600493. View

Gallezot J, Bottlaender M, Gregoire M, Roumenov D, Deverre J, Coulon C . In vivo imaging of human cerebral nicotinic acetylcholine receptors with 2-18F-fluoro-A-85380 and PET. J Nucl Med. 2005; 46(2):240-7. View

Chefer S, Horti A, Lee K, Koren A, Jones D, Gorey J . In vivo imaging of brain nicotinic acetylcholine receptors with 5-[123I]iodo-A-85380 using single photon emission computed tomography. Life Sci. 1998; 63(25):PL355-60. DOI: 10.1016/s0024-3205(98)00514-1. View

10.

Kimes A, Chefer S, Matochik J, Contoreggi C, Vaupel D, Stein E . Quantification of nicotinic acetylcholine receptors in the human brain with PET: bolus plus infusion administration of 2-[18F]F-A85380. Neuroimage. 2007; 39(2):717-27. PMC: 2386978. DOI: 10.1016/j.neuroimage.2007.09.015. View

11.

Esterlis I, Hannestad J, Perkins E, Bois F, DSouza D, Tyndale R . Effect of a nicotine vaccine on nicotine binding to β2*-nicotinic acetylcholine receptors in vivo in human tobacco smokers. Am J Psychiatry. 2013; 170(4):399-407. PMC: 3738000. DOI: 10.1176/appi.ajp.2012.12060793. View

12.

Fischer S, Hiller A, Smits R, Hoepping A, Funke U, Wenzel B . Radiosynthesis of racemic and enantiomerically pure (-)-[18F]flubatine--a promising PET radiotracer for neuroimaging of α4β2 nicotinic acetylcholine receptors. Appl Radiat Isot. 2013; 74:128-36. DOI: 10.1016/j.apradiso.2013.01.002. View

13.

Kuwabara H, Wong D, Gao Y, Valentine H, Holt D, Ravert H . PET Imaging of nicotinic acetylcholine receptors in baboons with 18F-AZAN, a radioligand with improved brain kinetics. J Nucl Med. 2011; 53(1):121-9. DOI: 10.2967/jnumed.111.092338. View

14.

Papademetris X, Jackowski A, Schultz R, Staib L, Duncan J . Integrated Intensity and Point-Feature Nonrigid Registration. Med Image Comput Comput Assist Interv. 2011; 3216(2004):763-770. PMC: 2869095. DOI: 10.1901/jaba.2001.3216-763. View

15.

Cunningham V, Rabiner E, Slifstein M, Laruelle M, Gunn R . Measuring drug occupancy in the absence of a reference region: the Lassen plot re-visited. J Cereb Blood Flow Metab. 2009; 30(1):46-50. PMC: 2949110. DOI: 10.1038/jcbfm.2009.190. View

16.

Kealey S, Plisson C, Collier T, Long N, Husbands S, Martarello L . Microfluidic reactions using [11C]carbon monoxide solutions for the synthesis of a positron emission tomography radiotracer. Org Biomol Chem. 2011; 9(9):3313-9. DOI: 10.1039/c0ob00631a. View

17.

Ding Y, Fowler J . New-generation radiotracers for nAChR and NET. Nucl Med Biol. 2005; 32(7):707-18. DOI: 10.1016/j.nucmedbio.2005.04.017. View

18.

Saricicek A, Esterlis I, Maloney K, Mineur Y, Ruf B, Muralidharan A . Persistent β2*-nicotinic acetylcholinergic receptor dysfunction in major depressive disorder. Am J Psychiatry. 2012; 169(8):851-9. PMC: 3494404. DOI: 10.1176/appi.ajp.2012.11101546. View

19.

Warpman U, Nordberg A . Epibatidine and ABT 418 reveal selective losses of alpha 4 beta 2 nicotinic receptors in Alzheimer brains. Neuroreport. 1995; 6(17):2419-23. DOI: 10.1097/00001756-199511270-00033. View

20.

Patt M, Schildan A, Habermann B, Fischer S, Hiller A, Deuther-Conrad W . Fully automated radiosynthesis of both enantiomers of [18F]Flubatine under GMP conditions for human application. Appl Radiat Isot. 2013; 80:7-11. DOI: 10.1016/j.apradiso.2013.05.009. View